by Kinnate | Sep 9, 2020 | News
Kinnate Biopharma Appoints Dean J. Mitchell as Chairman of the Board Laurie Smaldone Alsup, M.D. also joins as a board member SAN DIEGO, Calif.— September 9, 2020 — Kinnate Biopharma Inc., a biopharmaceutical company focused on the discovery and development of small...
by Kinnate | Aug 26, 2020 | News
Kinnate Biopharma Closes $98 Million Series C Financing Proceeds will be used to scale programs focused on advancing the company’s portfolio of kinase inhibitors into clinical testing next year SAN DIEGO, Calif.— August 26, 2020 — Kinnate Biopharma Inc., a...
by Kinnate | Jul 8, 2020 | News
Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer Company further expands its leadership team with the appointment of 20-year Pfizer veteran Dr. Robert Kania, as Senior Vice President, Drug Discovery SAN DIEGO, Calif.— July 8, 2020 — Kinnate...
by Kinnate | Jun 17, 2020 | Article
Precision Oncology News: Kinnate Exiting Stealth Mode With Plans to Move Lead RAF Inhibitor Into Clinical Trials Next Year June 16, 2020Most BRAF inhibitors that have been commercialized to date, or are being studied, go after BRAF V600 mutations, according to Kinnate...
Recent Comments